"Kidney Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes of the KIDNEY or its component tissues.
| Descriptor ID |
D007674
|
| MeSH Number(s) |
C12.777.419 C13.351.968.419
|
| Concept/Terms |
Kidney Diseases- Kidney Diseases
- Disease, Kidney
- Diseases, Kidney
- Kidney Disease
|
Below are MeSH descriptors whose meaning is more general than "Kidney Diseases".
Below are MeSH descriptors whose meaning is more specific than "Kidney Diseases".
This graph shows the total number of publications written about "Kidney Diseases" by people in this website by year, and whether "Kidney Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 2 | 6 |
| 1997 | 3 | 1 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 2 | 5 |
| 2000 | 2 | 2 | 4 |
| 2001 | 8 | 0 | 8 |
| 2002 | 5 | 1 | 6 |
| 2003 | 6 | 2 | 8 |
| 2004 | 9 | 5 | 14 |
| 2005 | 10 | 4 | 14 |
| 2006 | 14 | 4 | 18 |
| 2007 | 19 | 3 | 22 |
| 2008 | 13 | 3 | 16 |
| 2009 | 20 | 1 | 21 |
| 2010 | 26 | 5 | 31 |
| 2011 | 21 | 2 | 23 |
| 2012 | 12 | 6 | 18 |
| 2013 | 11 | 5 | 16 |
| 2014 | 7 | 4 | 11 |
| 2015 | 9 | 1 | 10 |
| 2016 | 9 | 4 | 13 |
| 2017 | 13 | 3 | 16 |
| 2018 | 4 | 3 | 7 |
| 2019 | 8 | 2 | 10 |
| 2020 | 21 | 2 | 23 |
| 2021 | 11 | 2 | 13 |
| 2022 | 15 | 0 | 15 |
| 2023 | 14 | 0 | 14 |
| 2024 | 6 | 5 | 11 |
| 2025 | 7 | 0 | 7 |
| 2026 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney Diseases" by people in Profiles.
-
Food Insecurity and Cardiovascular-Kidney-Metabolic Syndrome-Related Conditions Among US Adults, National Health and Nutrition Examination Survey, 2015-2020. Prev Chronic Dis. 2026 Aug 27; 23:E36.
-
Ultrasound-guided renal artery administration of angiopoietin-1 RNA therapy slows the progression of preclinical WT1 glomerular disease. Sci Transl Med. 2026 Aug 12; 18(862):eadv1289.
-
Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 2: from initiation to publication: the KDIGO guideline development process. Kidney Int. 2026 Oct; 110(4):834-840.
-
Longitudinal study of cardiovascular-kidney-metabolic syndrome risk assessment among adolescents and young adults (10-45 years) in Pakistan (LIFECARD): Study design and methodology. Prog Cardiovasc Dis. 2026 Mar-Apr; 95:46-53.
-
Mortality Estimation in Renal Disease (MERD Score): A Model Predicting Waitlist Mortality in Kidney Transplant Candidates. Transplant Proc. 2026 Jan-Feb; 58(1):83-93.
-
Phytoconstituents as therapeutic agents in combating methotrexate-induced hepatotoxicity and nephrotoxicity. Expert Opin Drug Metab Toxicol. 2025 Nov-Dec; 21(11-12):1287-1305.
-
Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicity. Toxicol Appl Pharmacol. 2025 Dec; 505:117543.
-
Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. Radiat Prot Dosimetry. 2025 Aug 26; 201(13-14):995-1005.
-
Protection against vancomycin-associated nephrotoxicity by zileuton: role of mitochondria revealed by electron microscopic study. Ultrastruct Pathol. 2025; 49(5):414-420.
-
Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicity. Antimicrob Agents Chemother. 2025 08 06; 69(8):e0028725.